Overall rank by patents
#46,494
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 19 technology areas, active 2022–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F16L (PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL).
The verdict
Exotex holds 5 US patents across 19 technology areas, rank #46,494 of 50,000 tracked assignees.
Exotex, Inc. has been granted 5 US utility patents between 2022 and 2024, placing Exotex, Inc. at rank #46,494 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.6 claims per patent with primary concentration in F16L (PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL). As a US Corporation, Exotex, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Exotex sits between Exoiq Gmbh (5 patents, rank #46,490) and Exsomed International IP, Llc (5 patents, rank #46,498) - the closest US assignees by grant volume. The composite Innovation Score of 51.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2024, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Exotex, Inc.'s 16.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Exotex, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
EXOIQ GMBH
5 patents
EXONHIT THERAPEUTICS, SA
5 patents
EXOSTEMTECH CO., LTD.
5 patents
EXOTEC SOLUTIONS
5 patents
EXPANDED EXISTENCE, INC.
5 patents
EXPANSE, INC.
5 patents
EXPERTUS KEMITEKNIK AB
5 patents
EXSOMED INTERNATIONAL IP, LLC
5 patents
EXOTEX, INC.
5 patents
What this shows Exotex holds 5 patents at rank #46,494, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #46,494 in granted patent volume.
Other assignees with the most granted patents in Exotex's primary technology class.
Exotex's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
| 2024 | 3 | 60.0% |
Top 15 of 19 technology areas
Overall rank by patents
#46,494
Across all tracked assignees
51.6 out of 100
How to use this portfolio
Exotex's 5 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.